Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	107.91	141.79	118.32	151.89
Short-Term Investments	419.38	378.86	277.14	-
Cash & Short-Term Investments	527.29	520.65	395.46	151.89
Cash Growth	0.24%	31.66%	160.36%	-
Other Receivables	4.48	4.7	1.21	-
Receivables	4.48	4.7	1.21	-
Prepaid Expenses	7.41	2.62	1.74	0.11
Other Current Assets	0.92	1.74	-	0.06
Total Current Assets	540.1	529.71	398.41	152.06
Property, Plant & Equipment	15.68	13.32	2.59	-
Long-Term Investments	61.64	210.42	-	-
Other Long-Term Assets	8.74	0.5	0.4	-
Total Assets	626.16	753.95	401.4	152.06
Accounts Payable	0.38	1.07	2.14	0.42
Accrued Expenses	29.59	24.26	17.31	9.56
Current Portion of Leases	4.08	3.23	1.1	-
Total Current Liabilities	34.05	28.56	20.56	9.98
Long-Term Leases	5.77	8.6	0.93	-
Total Liabilities	39.82	37.16	21.49	9.98
Common Stock	0	0	-	2.25
Additional Paid-In Capital	1,078	1,022	503.35	-
Retained Earnings	-492.37	-305.92	-123.77	-39.79
Comprehensive Income & Other	1.03	0.92	0.33	2.14
Total Common Equity	586.34	716.79	379.91	-35.39
Shareholders' Equity	586.34	716.79	379.91	142.08
Total Liabilities & Equity	626.16	753.95	401.4	152.06
Total Debt	9.85	11.83	2.03	-
Net Cash (Debt)	579.08	719.24	393.43	151.89
Net Cash Growth	-21.92%	82.82%	159.02%	-
Net Cash Per Share	9.96	13.03	15.73	61.69
Filing Date Shares Outstanding	67.49	58.09	48.52	5
Total Common Shares Outstanding	59.32	58.06	48.52	5
Working Capital	506.05	501.15	377.85	142.08
Book Value Per Share	9.89	12.35	7.83	-7.08
Tangible Book Value	586.34	716.79	379.91	-35.39
Tangible Book Value Per Share	9.89	12.35	7.83	-7.08
Machinery	4.16	1.29	-	-
Leasehold Improvements	3.08	0.86	-	-

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q